BIOLASE Introduces Next Generation Diode Laser, the EPIC 10(TM)
May 04 2012 - 9:00AM
Marketwired
BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental
laser manufacturer and distributor, today announced the
introduction of the EPIC 10™, the next generation of BIOLASE's
Total Diode Solution. The EPIC 10 is being demonstrated at CDA
Presents: Anaheim 2012, the California Dental Association's annual
tradeshow, being held May 3-5 at the Anaheim Convention Center in
Anaheim, CA, and several other concurrent and upcoming dental
industry events. EPIC 10 is not yet available for sale in the U.S.
as it is pending 510k clearance from the Food and Drug
Administration ("FDA").
This next generation, diode soft-tissue laser will have the
shortest pulse available in the market today. Short pulses are
known to cause less thermal damage in tissue and produce cleaner
cuts. In addition, the EPIC 10 will have a built-in battery for a
full day of operation and will be used as a design platform to
build more powerful versions with different combinations of laser
wavelengths.
Federico Pignatelli, Chairman and CEO, said, "The EPIC 10
represents yet another important innovation at BIOLASE and an
evolution of diode soft-tissue dental laser technology. The ability
to combine 15 of the most commonly performed soft-tissue
procedures, including 20-minute laser whitening and temporary oral
pain relief, in one device is a true innovation for our customers
and their patients. The BIOLASE engineering and marketing teams
continue to lead the dental technology community in advancing laser
technology with a focus on providing new tools to improve both the
clinical results and the return-on-investment of dental practices.
The EPIC 10 is a great example of such combined focus."
The EPIC 10 features a 940nm wavelength with 10 watts of real
power as well as an intuitive procedure-based graphical
touchscreen. It also uses BIOLASE's proprietary ComfortPulse™
control technology that helps to prevent potential tissue damage
and keeps patients comfortable by avoiding pain-inducing heat
buildup at the surgical site.
Neither EPIC 10, nor any claims of efficacy attached to it, are
yet cleared by the FDA. There is no guarantee that the FDA will
approve the device, nor any timeframe upon which such approval may
occur.
About BIOLASE Technology, Inc. BIOLASE
Technology, Inc., the World's leading Dental Laser Company, is a
medical technology company that develops, manufactures and markets
dental lasers and also distributes and markets dental imaging
equipment, products that are focused on technologies that advance
the practice of dentistry and medicine. The Company's laser
products incorporate 285 patented and patent pending technologies
designed to provide clinically superior performance with less pain
and faster recovery times. Its imaging products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
dental laser systems that perform a broad range of dental
procedures, including cosmetic and complex surgical applications,
and a full line of dental imaging equipment. BIOLASE has sold more
than 19,000 lasers among 16,000 customers. Other products under
development address ophthalmology and other medical and consumer
markets.
For updates and information on laser and Waterlase dentistry,
find BIOLASE at http://www.biolase.com, Twitter at
http://twitter.com/GoWaterlase, and YouTube at
http://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within
the meaning of safe harbor provided by the Securities Reform Act of
1995 that are based on the current expectations and estimates by
BIOLASE management. These forward-looking statements can be
identified through the use of words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
"may," "will," and variations of these words or similar
expressions. Forward-looking statements are based on management's
current, preliminary expectations and are subject to risks,
uncertainties and other factors which may cause the Company's
actual results to differ materially from the statements contained
herein, and are described in the Company's reports it files with
the Securities and Exchange Commission, including its annual and
quarterly reports. No undue reliance should be placed on
forward-looking statements. Such information is subject to change,
and BIOLASE undertakes no obligation to update such statements.
Image Available:
http://www2.marketwire.com/mw/frame_mw?attachid=1971661
For further information, please contact: Jill Bertotti Allen
& Caron +1-949-474-4300 jill@allencaron.com
Biolase (NASDAQ:BLTI)
Historical Stock Chart
From Apr 2024 to May 2024
Biolase (NASDAQ:BLTI)
Historical Stock Chart
From May 2023 to May 2024